Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Confronting a bird flu outbreak in nature presents unique challenges, as infected animals leave a landscape contaminated, Pa.

The London-based contract research organisation testing vaccines for infectious and respiratory diseases said it will use its RSV human challenge model to test IN-002 in a randomised, double-blinded ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

• Respiratory syncytial virus (RSV) infections are above the alert level. • Seasonal influenza (flu) infections are well ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

Nigeria faces unique challenges in addressing the potential threat posed by HMPV. These include limited diagnostic capacity, ...